- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04403191
Usage of Multiple Drugs in Treatment of Postoperative Vomiting After Laparoscopic Appendectomy
May 27, 2020 updated by: King Abdul Aziz Specialist Hospital
Comparative Study Between Ondansetron, Isopropyl Alcohol Inhalation and Super Hydration in Treatment of Postoperative Emesis After Laparoscopic Appendectomy
To compare and evaluate the antiemetic effect and the safety of ondansetron, inhalational isopropyl alcohol and super hydration on adult patients after laparoscopic appendectomy.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This prospective double-blind study done on 240 patients admitted to surgical I.C.U after laparoscopic appendectomy.
Those who had preoperative Koivuranta vomiting score of more than 3 enrolled in our study.
Every group contains 80 patients.
Patients of group A received ondansetron 4 mg intravenous immediately once reached to I.C.U and another same dose after 6 hours while patients of group B received isopropyl alcohol 70% inhalation every 15 min for 4 times then repeated after 6 hours.
The last group C received intravenous normal saline at rate of 20 ml/kg over 30 minute and repeated by the same dose after 6 hours.
The duration of the study was 24 hours post-operatively.
As PONV is self-limited within 24 hours.
Study Type
Observational
Enrollment (Actual)
240
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taif, Saudi Arabia, 21944
- King abd el Aziz specialist hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
240 patients admitted to surgical I.C.U of King Abdul-Aziz specialist hospital for post-operative care after laparoscopic appendectomy surgery between March 2019 till February 2020.
A Koivuranta Score to Predict Postoperative Nausea and Vomiting done preoperatively for all the patients and only those who had score of more than 3 on Koivuranta vomiting score (had more than 60% chance to develop PONV) enrolled in our study.
And randomly allocated in one of three groups group A, B or C.
Description
Inclusion Criteria:
postoperative nausea and vomiting
Exclusion Criteria:
systemic disease as diabetes or hypertension local gastric diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group A
received ondansetron 4 mg intravenous immediately once reached to I.C.U and another same dose after 6 hours
|
ondansetron 4 mg intravenous immediately once reached to I.C.U and another same dose after 6 hours while patients of group
all patients received post operatively after laparoscopic appenectomy
|
|
Group B
received isopropyl alcohol 70% inhalation every 15 min for 4 times then repeated after 6 hours
|
all patients received post operatively after laparoscopic appenectomy
inhalation every 15 min for 4 times then repeated after 6 hours
|
|
Group C
received intravenous normal saline at rate of 20 ml/kg over 30 minute and repeated by the same dose after 6 hours.
|
all patients received post operatively after laparoscopic appenectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
numbers of vomiting attacks
Time Frame: for one day
|
numbers of vomiting attacks recorded every 15 minutes for one day
|
for one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2019
Primary Completion (Actual)
February 4, 2020
Study Completion (Actual)
February 10, 2020
Study Registration Dates
First Submitted
May 20, 2020
First Submitted That Met QC Criteria
May 25, 2020
First Posted (Actual)
May 27, 2020
Study Record Updates
Last Update Posted (Actual)
May 28, 2020
Last Update Submitted That Met QC Criteria
May 27, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Signs and Symptoms, Digestive
- Vomiting
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Antiemetics
- Gastrointestinal Agents
- Dermatologic Agents
- Antipsychotic Agents
- Tranquilizing Agents
- Psychotropic Drugs
- Serotonin Agents
- Serotonin Antagonists
- Anti-Anxiety Agents
- Antipruritics
- Ondansetron
Other Study ID Numbers
- ICU-10-20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
To compare and evaluate the antiemetic effect and the safety of ondansetron, inhalational isopropyl alcohol and super hydration on adult patients after laparoscopic appendectomy.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ondansetron
-
Tanta UniversityRecruitingCesarean Section | Prevention | Shivering | Ondansetron | Intravenous | LozengeEgypt
-
Tanta UniversityRecruitingTonsillectomy | Shivering | Ondansetron | Intravenous | LozengeEgypt
-
Luxena Pharmaceuticals, Inc.Altasciences Company Inc.CompletedPostoperative Nausea and VomitingCanada
-
Chongqing University Cancer HospitalRecruitingPediatric Cancer | Radiotherapy-induced Nausea and Vomiting (RINV)China
-
Peking Union Medical College HospitalNot yet recruitingEsophagogastroduodenoscopy | Upper Gastrointestinal Bleeding (UGIB)
-
Washington University School of MedicineCompleted
-
AIPING ZHOUHenan Cancer HospitalNot yet recruitingChemotherapy-Induced Nausea and Vomiting (CINV)
-
Merck Sharp & Dohme LLCCompletedChemotherapy-Induced Nausea and Vomiting
-
Seoul National University Bundang HospitalRecruiting